Amag Pharmaceuticals (AMAG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Sales | 17,880 | 21,144 | 17,742 | 31,012 | 15,480 |
| Cost of Goods | 2,942 | 4,027 | 4,323 | 3,224 | 2,646 |
| Gross Profit | 14,938 | 17,117 | 13,419 | 27,788 | 12,834 |
| Operating Expenses | 20,351 | 21,154 | 18,305 | 24,054 | 26,289 |
| Operating Income | -4,471 | -4,010 | -4,563 | 3,958 | -12,809 |
| Other Income | 576 | 263 | 297 | -1,133 | 393 |
| Pre-tax Income | -3,895 | -3,747 | -4,266 | 2,825 | -12,416 |
| Income Tax | N/A | -61 | -299 | -494 | N/A |
| Net Income Continuous | -3,895 | -3,686 | -3,967 | 3,319 | -12,416 |
| Net Income | $-3,895 | $-3,686 | $-3,967 | $3,319 | $-12,416 |
| EPS Basic Total Ops | -0.18 | -0.17 | -0.19 | 0.16 | -0.58 |
| EPS Basic Continuous Ops | -0.18 | -0.17 | -0.19 | 0.16 | -0.58 |
| EPS Diluted Total Ops | -0.18 | -0.16 | -0.19 | 0.15 | -0.58 |
| EPS Diluted Continuous Ops | -0.18 | -0.17 | -0.19 | 0.15 | -0.58 |
| EBITDA(a) | $-3,140 | $-3,041 | $-2,525 | $5,526 | $-11,492 |